Apex Biotechnology Corp (1733) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Apex Biotechnology Corp (1733) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$5.19 Million ≈ $163.42K USD) by net assets (NT$1.81 Billion ≈ $57.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Apex Biotechnology Corp net asset quality index to measure how much of total assets are equity-financed.

Apex Biotechnology Corp - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Apex Biotechnology Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Apex Biotechnology Corp (1733) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Apex Biotechnology Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Apex Biotechnology Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Samhaellsbyggnadsbolaget i Norden AB Series D ST:SBB-D	-0.001x
Shanghai Diesel Engine Co Ltd B SHG:900920	0.050x
Hites S.A. SN:HITES	0.142x
Serrano 61 Desarrollo SOCIMI SA MC:YSRR	-0.002x
TMT Investments PLC LSE:TMT	-0.003x
Cornerstone OnDemand Inc F:8CO	0.014x
Creepy Jar SA WAR:CRJ	0.241x
Townsquare Media Inc NYSE:TSQ	-0.116x

Annual Cash Flow Conversion Efficiency for Apex Biotechnology Corp (2002–2024)

The table below shows the annual cash flow conversion efficiency of Apex Biotechnology Corp from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see 1733 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.82 Billion ≈ $57.47 Million	NT$328.67 Million ≈ $10.35 Million	0.180x	+40.52%
2023-12-31	NT$1.80 Billion ≈ $56.61 Million	NT$230.39 Million ≈ $7.26 Million	0.128x	+775.71%
2022-12-31	NT$1.82 Billion ≈ $57.27 Million	NT$26.62 Million ≈ $838.55K	0.015x	-85.73%
2021-12-31	NT$1.75 Billion ≈ $55.25 Million	NT$179.87 Million ≈ $5.67 Million	0.103x	-39.83%
2020-12-31	NT$1.65 Billion ≈ $51.86 Million	NT$280.60 Million ≈ $8.84 Million	0.170x	-38.20%
2019-12-31	NT$1.68 Billion ≈ $52.83 Million	NT$462.52 Million ≈ $14.57 Million	0.276x	+571.12%
2018-12-31	NT$1.64 Billion ≈ $51.79 Million	NT$67.57 Million ≈ $2.13 Million	0.041x	-3.39%
2017-12-31	NT$1.66 Billion ≈ $52.45 Million	NT$70.83 Million ≈ $2.23 Million	0.043x	-75.27%
2016-12-31	NT$1.73 Billion ≈ $54.58 Million	NT$298.06 Million ≈ $9.39 Million	0.172x	-29.67%
2015-12-31	NT$1.93 Billion ≈ $60.80 Million	NT$472.15 Million ≈ $14.88 Million	0.245x	+70.64%
2014-12-31	NT$1.87 Billion ≈ $58.80 Million	NT$267.60 Million ≈ $8.43 Million	0.143x	-43.20%
2013-12-31	NT$1.92 Billion ≈ $60.51 Million	NT$484.77 Million ≈ $15.27 Million	0.252x	-0.31%
2012-12-31	NT$2.01 Billion ≈ $63.41 Million	NT$509.67 Million ≈ $16.06 Million	0.253x	+62.08%
2011-12-31	NT$1.75 Billion ≈ $55.14 Million	NT$273.45 Million ≈ $8.62 Million	0.156x	-45.31%
2010-12-31	NT$1.63 Billion ≈ $51.35 Million	NT$465.59 Million ≈ $14.67 Million	0.286x	+7.41%
2009-12-31	NT$1.47 Billion ≈ $46.35 Million	NT$391.29 Million ≈ $12.33 Million	0.266x	+12.09%
2008-12-31	NT$1.26 Billion ≈ $39.83 Million	NT$299.96 Million ≈ $9.45 Million	0.237x	-12.21%
2007-12-31	NT$1.35 Billion ≈ $42.50 Million	NT$364.62 Million ≈ $11.49 Million	0.270x	-18.07%
2006-12-31	NT$1.10 Billion ≈ $34.74 Million	NT$363.71 Million ≈ $11.46 Million	0.330x	+39.47%
2005-12-31	NT$896.93 Million ≈ $28.26 Million	NT$212.14 Million ≈ $6.68 Million	0.237x	-6.29%
2004-12-31	NT$865.91 Million ≈ $27.28 Million	NT$218.54 Million ≈ $6.89 Million	0.252x	-29.66%
2003-12-31	NT$842.42 Million ≈ $26.54 Million	NT$302.25 Million ≈ $9.52 Million	0.359x	+221.73%
2002-12-31	NT$712.76 Million ≈ $22.46 Million	NT$79.49 Million ≈ $2.50 Million	0.112x	--

About Apex Biotechnology Corp

TW:1733 Taiwan Biotechnology

Market Cap

$98.56 Million

NT$3.13 Billion TWD

Market Cap Rank

#19174 Global

#1061 in Taiwan

Share Price

NT$31.30

Change (1 day)

-1.42%

52-Week Range

NT$28.20 - NT$37.50

All Time High

NT$42.96